← The Wire
CMPXNasdaq
Compass Therapeutics, Inc.
Biological Products, (No Diagnostic Substances) · DE · CIK 1738021
Developing antibody-based cancer therapeutics targeting angiogenesis, immune response, and tumor growth
$366M
Market cap
$2.16
Last close
+3.9%
1D
+2.9%
5D
2.8M
Volume
Price · last 39 sessions+11.3%
May 4L $1.81 · H $2.41Jun 29
122
Total filings
Jun 23, 2026
Last filing
12/31
Fiscal year end
424B5424B5Aug 13, 2025424B5424B5Aug 12, 2025424B5424B5Aug 1, 2022424B5424B5Dec 15, 2021424B5424B5Dec 15, 2021424B5424B5Nov 3, 2021424B5424B5Nov 1, 2021
Similar companies
Comparable business profile · signals at a glance